Repeat or New Trend?

The last time The PPT registered such a low reading was on 6/24/13, when the SPY was at $157. Ever since then, the market ripped higher and never looked back. With over 75% of stocks lower for the day, very few of you are fortunate enough to be making money today. Naturally, Bill Ackman is down again in his HLF short, but that’s because he’s cursed and doomed for a decade of failure.

Everything I own is down and it chagrins me to give back what I earned. However, there is nothing worse than compounding one’s mistakes by selling at the bottom of the range.

We can trade lower and the market is designed to fool the idiot into surrendering his money. But the odds are in favor of the guy eating a hamburger, sloppily moping around the office, buying this dip.

I will not be putting money to work today. I don’t like catching knives and already caught a few with IMMR yesterday. I will be elated to see the market trade higher tomorrow and will buy more then, into strength.

I am really pissed off to have missed out on the LITB run. If I was a chinese male, I’d likely boil a dog for dinner.

Let’s not waste time with small talk, friendo. There are things to do, people to talk to, and money to snatch. Instead of giving you bozos are long list of stocks that you’re never going to research, I am going to give you just three.

What you do with these three securities is entirely up to you.

ICEL
CTRL
FLTX

Pick one and shut up about it.

I had a small drawdown today. This isn’t much of a pullback and I urinate on those who ridicule me in the comments section for holding at new highs. You don’t know what you are doing and have never made millions in the markets. I do not understand what makes you think you are qualified to talk to a person, such as myself.

Stupid, vile creatures, who inject crack cocaine into collapsed veins, should never visit iBC, let alone offer me financial advice. The idea, mind you, that owning stocks at new highs is a bad idea is preposterous. Nine out of 10 times, the market will continue even higher. The people who are bearish at the tops have a track record of success of 10%, nothing more.

It’s a down day, but so what. I added to IMMR, haven’t sold a share of YELP and that’s how I roll. I am either going to be proven correct or wrong.

I play the game to win and never look back or regret my mistakes–because they are lessons that will help me get better.

I added to my IMMR position, like a boss.

All of my stocks are getting lit, especially IMMR. I can’t pretend to be surprised. After all, the stock reversed on big volume on earnings day, throwing me through the windshield. But that’s the reason why I sold 30% of my position ahead of earnings–to buy it back. The stock is low enough for me to buy back now. I’d have to hold onto this sucker for another quarter or two. But I intended to do that anyway.

The market is lower due to profit taking. That’s all. It might rebound today or it might rebound next week. Rest assured: it will rebound.

The game plan, for now, is to absorb the licks as best I can, plot and scheme to utilize the cash on hand (20%) to acquire some bargains.

All of the youngsters are playing this bull run with reckless abandon; and that’s a good thing. I know it sounds cliche, but the older you get, the more you fear. Then we get so old that anything short of a coronary is child’s play, enabling us to display pseudo courage at the tender age of 90.

Some of us are just reckless, willing to lose everything just to make it big. This is the classic mistake that most of you penis holders make. If you don’t have an edge, don’t take the risk, pal. You have no business doing what I do, since I do it better, vis a vie years of hard fought experience.

I’ve been playing the stock market since I was 10 years old. Although I never turned birthday gifts into millions, I’ve managed to pull myself up from the dirt into the upper middle class. The upper class is now populated with people disconnected from the planet, totally insane, coked up or downed out.

But I’m not done yet.

I will use the talents that I have to finance the Orbital Space Cannon (OSC) programmes, meant to be used for offensive and authoritarian means only. Defense is for shoe shiners.

No, I am not afraid to buy at the highs because it’s only money. I’ve made and lost fortunes and will do so again. That’s the nature of the game. Play to win or don’t play at all.

There are plenty of high beta names that I will be involved in, from now until 12/31. But I’d be hard pressed to find a stock with a better story than POWI. It is my top idea for the remainder of the year.

What’s yours?

As an aside, we are in the final stages of launching The Option Addict’s Premium service. The guy has been killing it. Free trials forthcoming.

If you are wondering where you can find stocks that are unknown, perhaps undervalued, look no further than the ipo market. As an index, they are up more than 30% this year and keep spinning higher. This is speculation at its best and I am game.

Inside the hallowed halls of The PPT, I created a screen that can search out ipos. Here are the outperformers, over the past month:

ADHD (DEVIL PICK AT $7)

AMBI

INSY

RNA

YY

TRLA

PRTA

MKTO

XOOM

ECOM

And here are the underperformers:

LPDX

CMRX

ATOS

RLGY

FWM

HASI

AHH

TMHC

DXM

The one’s that are ripping today are ONTX, IPDN, KBIO, LITB, SCTY, CNAT, LIQD, SALE, STML and YY.

To pick the right one, I suggest starting with volume, believe it or not. Some of these stocks are too illiquid and can serve as a ‘roach motel’ if the market sours. I’d then look for relative strength, keeping my screens focused on tech and healthcare.

I cannot believe my eyes, SPEX is parabolic to the upside, as well as a half dozen small cap biotechs. I’ve purposely avoided this space, due to my handicap in the field of medicine. However and apparently, none of that is needed in order to become a very successful biotech investor. People who’ve delved into this space have gotten rich, very rich.

Nonetheless, the runs will continue, as the Baby Boomers (the worst generation since the dark ages) die on an industrial scale.

There are several that I am eyeballing and have requested the assistance of some people that I know in the medical profession. On the larger cap front, GILD seems to be the preferred stock, especially since their new HVC drug is likely to be approved this year.

If you have any small biotechs worth a look, let me know–as I am new and inexperienced in the space.

CNBC is reporting Bill ‘Montauk” Ackman was down 2.2% in July and up just 4% for the year. In other words, Bill, due to his retarded HLF short position and long JCP holdings, is in the bottom quadrant of professional money managers, as far as performance is concerned. Even still, he has over $11 billion under management.

Being the best doesn’t mean you will be the most successful. In this case, Bill is a terrific salesmen.